Philippe Généreux, MD, presented updated findings from one of cardiology's most closely watched trials at New York Valves 2026. 

 The clearance marks a key milestone in the company’s expansion into the North American market. 

Compensation for healthcare providers rose some 4.3% in 2025. The sobering news is that the gain owes more to heavier daily workloads than to bigger per-patient billings.